Ádám Dorottya

Name: Ádám Dorottya

Other profiles: MTMT

Publication list

Tudóstér co-authors statistics filterable publication list

Export to RIS (EndNote, Mendeley, RefWorks, Zotero etc.)

Upload publications

Request certified publication list

Uploaded publications:

Publications in DEA:

OA:

Date range:

2018-2025

2025

Ádám, D., Arany, J., Tóth, K. F., Póliska, S., Váradi, J., Kolozsi, P., Tóth, D., Niehues, H., van den Bogaard, E. H., Soeberdt, M., Abels, C., Oláh, A.: Fluoxetine exerts anti-proliferative effect in human epidermal keratinocytes.
Arch Dermatol Res. 317 (1), 1-6, (article identifier: 277), 2025.

doi DEA WoS

Journal metrics:

Q1 Dermatology (2024)

Q2 Medicine (miscellaneous) (2024)

Ádám, D., Arany, J., Tóth, K. F., Pető, O., Nyitrai, T., Tóth, I. B., Póliska, S., Zouboulis, C. C., Oláh, A.: The TRPM5 antagonist triphenylphosphine oxide (TPPO) increases sebaceous lipogenesis and modulates immune phenotype of human sebocytes in a TRPM5-independent manner.
Exp. Dermatol. 34 (5), 1-13, (article identifier: 70115), 2025.

doi DEA

Journal metrics:

Q1 Biochemistry (2024)

D1 Dermatology (2024)

Q2 Molecular Biology (2024)

2024

Tóth, K. F., Ádám, D., Arany, J., Ramirez, Y. A., Bíró, T., Drake, J. I., O'Mahony, A., Szöllősi, A. G., Póliska, S., Kilic, A., Soeberdt, M., Abels, C., Oláh, A.: Fluoxetine exerts anti-inflammatory effects on human epidermal keratinocytes and suppresses their endothelin release.
Exp. Dermatol. 33 (1), 1-15, (article identifier: 14988), 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry

D1 Dermatology

Q2 Molecular Biology

Dull, K., Ádám, D., Póliska, S., Aboud, H., Szegedi, A., Oláh, A., Töröcsik, D.: Sebum lipids selectively modulate gene expression in keratinocytes.
J. Invest. Dermatol. 144 (12), S264, 2024.

doi DEA

Ádám, D., Arany, J., Tóth, K. F., Pető, O., Nyitrai, T., Tóth, I. B., Póliska, S., Zouboulis, C. C., Oláh, A.: The TRPM5 antagonist triphenylphosphine oxide increases sebaceous lipogenesis and modulates immune phenotype of human sebocytes in a TRPM5-independent manner.
J. Invest. Dermatol. 144 (12_Suppl), S313, 2024.

doi DEA

2023

Arany, J., Ádám, D., Cseszlai, M., Nyitrai, T., Zouboulis, C. C., Oláh, A.: Adenosine receptors are novel regulators of human sebocyte biology.
J. Invest. Dermatol. 143 (Suppl_11), S355, 2023.

doi DEA

Tóth, K. F., Ádám, D., Arany, J., Ramirez, Y. A., Bíró, T., Drake, J. I., O'Mahony, A., Szöllősi, A. G., Kilic, A., Soeberdt, M., Abels, C., Oláh, A.: Fluoxetine exerts anti-inflammatory effects on human epidermal keratinocytes, and suppresses endothelin release via inhibiting PI3K.
J. Invest. Dermatol. 143 (5), S126, 2023.

doi DEA

Tóth, K. F., Ádám, D., Arany, J., Ramirez, Y. A., Bíró, T., Drake, J. I., O'Mahony, A., Szöllősi, A. G., Kilic, A., Soeberdt, M., Abels, C., Oláh, A.: Fluoxetine exerts anti-inflammatory effects on human epidermal keratinocytes, and suppresses their endothelin release.
J. Invest. Dermatol. 143 (11), S361, 2023.

doi DEA

Lőrincz, E. B., Tóth, G., Spolárics, J., Herczeg, M., Hodek, J., Zupkó, I., Minorics, R., Ádám, D., Oláh, A., Zouboulis, C. C., Weber, J., Nagy, L., Ostorházi, E., Bácskay, I., Borbás, A., Herczegh, P., Bereczki, I.: Mannich-type modifications of (-)-cannabidiol and (-)-cannabigerol leading to new, bioactive derivatives.
Sci. Rep. 13 (1), 19618, (article identifier: 19618), 2023.

doi DEA WoS Scopus

Journal metrics:

D1 Multidisciplinary

10.

Ádám, D., Arany, J., Pető, O., Tóth, I. B., Zouboulis, C. C., Oláh, A.: The TRPM5 antagonist TPPO increases sebaceous lipogenesis and exerts pro-inflammatory effects via activation of Akt and p38 MAPK cascades.
J. Invest. Dermatol. 143 (11), S354, 2023.

doi DEA

2022

11.

Ádám, D., Arany, J., Tóth, K. F., Tóth, I. B., Szöllősi, A. G., Oláh, A.: Opioidergic Signaling: a Neglected, Yet Potentially Important Player in Atopic Dermatitis.
Int. J. Mol. Sci. 23 (8), 4140, (article identifier: 4140), 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Catalysis

Q1 Computer Science Applications

D1 Inorganic Chemistry

Q1 Medicine (miscellaneous)

Q2 Molecular Biology

Q1 Organic Chemistry

Q1 Physical and Theoretical Chemistry

D1 Spectroscopy

2020

12.

Markovics, A., Angyal, Á., Tóth, K. F., Ádám, D., Pénzes, Z., Magi, J., Pór, Á., Kovács, I., Töröcsik, D., Zouboulis, C. C., Bíró, T., Oláh, A.: GPR119 is a potent regulator of human sebocyte biology.
J. Invest. Dermatol. 140 (10), 1909-1918, 2020.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry

Q1 Cell Biology

D1 Dermatology

Q1 Molecular Biology

2019

13.

Tóth, K. F., Ádám, D., Bíró, T., Oláh, A.: Cannabinoid signaling in the skin: therapeutic potential of the "c(ut)annabinoid" system.
Molecules. 24 (5), 918, 2019.

doi DEA WoS Scopus

Journal metrics:

Q2 Analytical Chemistry

Q2 Chemistry (miscellaneous)

Q2 Drug Discovery

Q2 Medicine (miscellaneous)

Q3 Molecular Medicine

Q2 Organic Chemistry

Q1 Pharmaceutical Science

Q2 Physical and Theoretical Chemistry

14.

Tóth, K. F., Ádám, D., Arany, J., Faragó, P., Arbiser, J. L., Zouboulis, C. C., Bíró, T., Oláh, A.: The putative tribbles homolog 3 (TRIB3) activator honokiol suppresses lipogenesis, and exerts anti-proliferative as well as anti-inflammatory effects on human sebocytes.
J. Invest. Dermatol. 139 (9S), S319, 2019.

doi DEA WoS

2018

15.

Ádám, D., Tóth, K. F., Sárkány, F., Soeberdt, M., Abels, C., Oláh, A., Bíró, T.: Activation of k-opioid receptor (KOR) suppresses pro-inflammatory response of human epidermal keratinocytes.
Exp. Dermatol. 27 (Suppl.), 38, 2018.

doi DEA WoS

16.

Tóth, K. F., Markovics, A., Ádám, D., Pénzes, Z., Angyal, Á., Magi, J., Pór, Á., Kovács, I., Zouboulis, C. C., Bíró, T., Oláh, A.: GPR119 is a potent novel regulator of human sebocyte biology.
Exp. Dermatol. 27 (Suppl.), 36-37, 2018.

doi DEA WoS